Solvar (SVR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 Oct, 2026Strategy and growth
Targets underserved consumers and small businesses, with growth plans across personal and commercial lending, productivity and disciplined capital allocation.
Commercial lending moved from start-up to growth, ending FY26 at $109.8m, up 88.2% YoY.
Funding capacity exceeds $400m, supporting future loan book growth; Money3 funder margins fell ~1% in FY26.
FY26 performance
Continuing Australian loan book was $920.3m; the reported loan book was $953.4m, including $33.1m in New Zealand. Australian loan book rose 10.5% YoY.
Australian originations reached $470.7m, up 21.0% YoY; Australian interest income was $180.3m.
Normalised NPAT was $36.1m, up 7.5% YoY; statutory NPAT was $29.5m, down 6.2% YoY. Normalised EPS was 19.0 cents, up 14.7%.
Fully franked dividends totalled 19.5 cents per share, up 39.3% YoY; 7.5m shares were repurchased for $11.5m at an average $1.54.
Portfolio quality and capital
Bad debts were 3.6%, down from 4.4% in FY25, including the one-off sale of New Zealand’s written-off book; Australian bad debts were 4.4%, up from 4.1%.
81% of the Australian portfolio was rated Strong or Good; leverage was 74%, with capacity to increase to ~80%, and unrestricted cash was $71.8m.
A new $488.0m Money3 warehouse facility supported planned growth over the next 12–24 months.
Since FY23, 31.9m shares were repurchased for $48.9m; shares outstanding fell 10.3% to 186.7m, at an average buyback price of $1.53.
Latest events from Solvar
- Normalized NPAT up 14.7%, loan book growth, and double-digit growth forecast for FY27.SVR
H2 2026 - NPAT and EPS grew, dividends increased, and funding expanded as NZ exit accelerated.SVR
H1 2026 - FY25 saw record NPAT and dividends, with FY26 targeting growth via new products and tech upgrades.SVR
AGM 2025 - Normalised NPAT up 17.4%, 5.3% Australian loan book growth, and 14.0 cent dividend declared.SVR
H2 2025 - Bennji launch and technology upgrades drive growth, with strong loan book quality and FY25 NPAT forecast at $34m.SVR
Investor Presentation - FY24 saw strong growth, a 10c dividend, and focus on tech, compliance, and legal risks.SVR
AGM 2024 - Normalised NPAT was $29.0m, with strong Australian loan book and revenue growth.SVR
H2 2024 - Normalised NPAT up 26.9%, EPS up 30%, dividend up 20%, and robust loan growth outlook.SVR
H1 2025